TreeWAS – Variant ID: rs1555115

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C44.3 Skin of other and unspecified parts of face	1.000	0.000	0.000
E10.9 Without complications	0.000	0.000	1.000
K51.9 Ulcerative colitis, unspecified	1.000	0.000	0.000
K90.0 Coeliac disease	0.000	0.000	1.000
C44 Other malignant neoplasms of skin	1.000	0.000	0.000
K51 Ulcerative colitis	1.000	0.000	0.000
J45.9 Asthma, unspecified	0.000	0.000	1.000
E10 Insulin-dependent diabetes mellitus	0.000	0.000	1.000
C44.7 Skin of lower limb, including hip	0.999	0.001	0.000
K50-K52 Noninfective enteritis and colitis	0.999	0.001	0.000
K50.1 Crohn's disease of large intestine	0.999	0.001	0.000
K50 Crohn's disease [regional enteritis]	0.999	0.001	0.000
K51.4 Pseudopolyposis of colon	0.993	0.007	0.000
Z93.2 Ileostomy status	0.992	0.008	0.000
C44.2 Skin of ear and external auricular canal	0.988	0.012	0.000
E10.3 With ophthalmic complications	0.000	0.013	0.987
E10.1 With ketoacidosis	0.000	0.013	0.987
C44.4 Skin of scalp and neck	0.985	0.015	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.985	0.015	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.979	0.021	0.000
C44.5 Skin of trunk	0.976	0.024	0.000
C44.6 Skin of upper limb, including shoulder	0.973	0.027	0.000
K51.8 Other ulcerative colitis	0.957	0.043	0.000
D86.9 Sarcoidosis, unspecified	0.000	0.049	0.951
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.950	0.050	0.000
D86 Sarcoidosis	0.000	0.053	0.947
K51.2 Ulcerative (chronic) proctitis	0.945	0.055	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.940	0.060	0.000
D86.0 Sarcoidosis of lung	0.000	0.061	0.939
C83.3 Large cell (diffuse)	0.937	0.063	0.000
C44.0 Skin of lip	0.937	0.063	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.924	0.076	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.906	0.094	0.000
C82.0 Small cleaved cell, follicular	0.891	0.109	0.000
K50.9 Crohn's disease, unspecified	0.887	0.113	0.000
D51 Vitamin B12 deficiency anaemia	0.000	0.135	0.864
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency	0.000	0.136	0.864
D50-D53 Nutritional anaemias	0.000	0.141	0.859
K52 Other non-infective gastro-enteritis and colitis	0.851	0.149	0.000
D80-D89 Certain disorders involving the immune mechanism	0.000	0.162	0.838
E10.8 With unspecified complications	0.000	0.165	0.835
K51.5 Mucosal proctocolitis	0.829	0.171	0.000
D50 Iron deficiency anaemia	0.000	0.175	0.825
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.000	0.177	0.823
D50.9 Iron deficiency anaemia, unspecified	0.000	0.178	0.822
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.816	0.184	0.000
D51.9 Vitamin B12 deficiency anaemia, unspecified	0.000	0.195	0.805
C82.3 Follicular lymphoma grade IIIa	0.793	0.207	0.000
C44.9 Malignant neoplasm of skin, unspecified	0.783	0.217	0.000
E10.0 With coma	0.000	0.233	0.767
C44.1 Skin of eyelid, including canthus	0.767	0.233	0.000
K52.1 Toxic gastro-enteritis and colitis	0.756	0.244	0.000
E10-E14 Diabetes mellitus	0.000	0.245	0.755
K90 Intestinal malabsorption	0.000	0.254	0.746
E10.4 With neurological complications	0.000	0.258	0.741
E10.6 With other specified complications	0.000	0.260	0.740
C83.1 Small cleaved cell (diffuse)	0.727	0.273	0.000
K51.3 Ulcerative (chronic) rectosigmoiditis	0.721	0.279	0.000
K50.8 Other Crohn's disease	0.720	0.280	0.000
K52.3 Indeterminate colitis	0.718	0.282	0.000
C44.8 Overlapping lesion of skin	0.717	0.283	0.000
E10.7 With multiple complications	0.000	0.283	0.717
K52.8 Other specified non-infective gastro-enteritis and colitis	0.716	0.284	0.000
C85.1 B-cell lymphoma, unspecified	0.715	0.285	0.000
K51.0 Ulcerative (chronic) enterocolitis	0.712	0.288	0.000
C82.2 Large cell, follicular	0.712	0.288	0.000
C43-C44 Melanoma and other malignant neoplasms of skin	0.709	0.291	0.000
C82.6 Cutaneous follicle centre lymphoma	0.702	0.298	0.000
C82.5 Diffuse follicle centre lymphoma	0.702	0.298	0.000
C82.4 Follicular lymphoma grade IIIb	0.702	0.298	0.000
E10.2 With renal complications	0.000	0.310	0.690
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.681	0.319	0.000
C94 Other leukaemias of specified cell type	0.681	0.319	0.000
C93 Monocytic leukaemia	0.681	0.319	0.000
C86 Other specified types of T/NK-cell lymphoma	0.681	0.319	0.000
D86.8 Sarcoidosis of other and combined sites	0.000	0.321	0.679
D86.3 Sarcoidosis of skin	0.000	0.321	0.679
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.000	0.321	0.679
D86.1 Sarcoidosis of lymph nodes	0.000	0.321	0.679
C83.6 Undifferentiated (diffuse)	0.674	0.326	0.000
C83.5 Lymphoblastic (diffuse)	0.674	0.326	0.000
C83.4 Immunoblastic (diffuse)	0.674	0.326	0.000
C83.2 Mixed small and large cell (diffuse)	0.674	0.326	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.672	0.328	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.671	0.329	0.000
E16.2 Hypoglycaemia, unspecified	0.000	0.336	0.664
E16 Other disorders of pancreatic internal secretion	0.000	0.337	0.663
Chapter IV Endocrine, nutritional and metabolic diseases	0.000	0.338	0.662
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.662	0.338	0.000
C85.0 Lymphosarcoma	0.662	0.338	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.000	0.338	0.662
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.000	0.339	0.661
C81 Hodgkin's disease	0.660	0.340	0.000
C83.7 Burkitt's tumour	0.653	0.347	0.000
D52 Folate deficiency anaemia	0.000	0.349	0.651
K51.1 Ulcerative (chronic) ileocolitis	0.647	0.353	0.000
C95 Leukaemia of unspecified cell type	0.627	0.373	0.000
K52.2 Allergic and dietetic gastro-enteritis and colitis	0.626	0.374	0.000
E10.5 With peripheral circulatory complications	0.000	0.377	0.623
D51.8 Other vitamin B12 deficiency anaemias	0.000	0.380	0.620
D51.3 Other dietary vitamin B12 deficiency anaemia	0.000	0.380	0.620
D51.2 Transcobalamin II deficiency	0.000	0.380	0.620
D51.1 Vitamin B12 deficiency anaemia due to selective vitamin B12 malabsorption with proteinuria	0.000	0.380	0.620
C84 Peripheral and cutaneous T-cell lymphomas	0.617	0.383	0.000
E20-E35 Disorders of other endocrine glands	0.000	0.387	0.613
C88 Malignant immunoproliferative diseases	0.603	0.397	0.000
D82 Immunodeficiency associated with other major defects	0.000	0.399	0.601
D81 Combined immunodeficiencies	0.000	0.399	0.601
E27 Other disorders of adrenal gland	0.000	0.399	0.601
E27.1 Primary adrenocortical insufficiency	0.000	0.402	0.598
D50.1 Sideropenic dysphagia	0.000	0.408	0.592
E13 Other specified diabetes mellitus	0.000	0.409	0.591
K90.9 Intestinal malabsorption, unspecified	0.000	0.410	0.590
D53 Other nutritional anaemias	0.000	0.410	0.590
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.584	0.415	0.000
D55-D59 Haemolytic anaemias	0.000	0.418	0.582
C85.7 Other specified types of non-Hodgkin's lymphoma	0.574	0.426	0.000
K90.8 Other intestinal malabsorption	0.000	0.439	0.561
E22 Hyperfunction of pituitary gland	0.000	0.442	0.558
E14 Unspecified diabetes mellitus	0.000	0.451	0.549
Chapter II Neoplasms	0.546	0.453	0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.546	0.454	0.000
C73 Malignant neoplasm of thyroid gland	0.544	0.456	0.000
E12 Malnutrition-related diabetes mellitus	0.000	0.459	0.541
K90.3 Pancreatic steatorrhoea	0.000	0.465	0.535
K90.2 Blind loop syndrome, not elsewhere classified	0.000	0.465	0.535
K90.1 Tropical sprue	0.000	0.465	0.535
E16.1 Other hypoglycaemia	0.000	0.473	0.527
C90 Multiple myeloma and malignant plasma cell neoplasms	0.526	0.474	0.000
D83 Common variable immunodeficiency	0.000	0.476	0.524
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.000	0.492	0.508
C81.1 Nodular sclerosis	0.507	0.492	0.000
E16.0 Drug-induced hypoglycaemia without coma	0.000	0.493	0.507
C81.2 Mixed cellularity	0.505	0.495	0.000
D52.9 Folate deficiency anaemia, unspecified	0.000	0.498	0.502
C81.0 Lymphocytic predominance	0.501	0.499	0.000
D59 Acquired haemolytic anaemia	0.000	0.500	0.500
D80 Immunodeficiency with predominantly antibody defects	0.000	0.501	0.498
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.488	0.511	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.488	0.511	0.000
C86.4 Blastic NK-cell lymphoma	0.488	0.511	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.488	0.511	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.488	0.511	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.488	0.511	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.488	0.511	0.000
C93.9 Monocytic leukaemia, unspecified	0.488	0.511	0.000
C93.7 Other monocytic leukaemia	0.488	0.511	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.488	0.511	0.000
C93.2 Subacute monocytic leukaemia	0.488	0.511	0.000
C93.1 Chronic monocytic leukaemia	0.488	0.511	0.000
C93.0 Acute monocytic leukaemia	0.488	0.511	0.000
C94.7 Other specified leukaemias	0.488	0.511	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.488	0.511	0.000
C94.5 Acute myelofibrosis	0.488	0.511	0.000
C94.4 Acute panmyelosis	0.488	0.511	0.000
C94.3 Mast cell leukaemia	0.488	0.511	0.000
C94.2 Acute megakaryoblastic leukaemia	0.488	0.511	0.000
C94.1 Chronic erythraemia	0.488	0.511	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.488	0.511	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.488	0.511	0.000
C96.8 Histiocytic sarcoma	0.488	0.511	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.488	0.511	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.488	0.511	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.488	0.511	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.488	0.511	0.000
C96.3 True histiocytic lymphoma	0.488	0.511	0.000
C96.2 Malignant mast cell tumour	0.488	0.511	0.000
C96.1 Malignant histiocytosis	0.488	0.511	0.000
C96.0 Letterer-Siwe disease	0.488	0.511	0.000
D84 Other immunodeficiencies	0.001	0.516	0.483
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.000	0.516	0.484
C91 Lymphoid leukaemia	0.478	0.521	0.001
E16.9 Disorder of pancreatic internal secretion, unspecified	0.000	0.524	0.476
E16.8 Other specified disorders of pancreatic internal secretion	0.000	0.524	0.476
E16.4 Abnormal secretion of gastrin	0.000	0.524	0.476
E16.3 Increased secretion of glucagon	0.000	0.524	0.476
E15 Nondiabetic hypoglycaemic coma	0.000	0.525	0.474
E13.9 Without complications	0.000	0.526	0.474
C81.7 Other Hodgkin's disease	0.473	0.526	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.473	0.526	0.000
C81.3 Lymphocytic depletion	0.473	0.526	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.528	0.472
E24 Cushing's syndrome	0.000	0.529	0.471
D52.8 Other folate deficiency anaemias	0.000	0.533	0.467
D52.1 Drug-induced folate deficiency anaemia	0.000	0.533	0.467
D52.0 Dietary folate deficiency anaemia	0.000	0.533	0.467
E27.2 Addisonian crisis	0.000	0.544	0.456
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.455	0.545	0.000
E14.9 Without complications	0.000	0.546	0.454
K52.0 Gastro-enteritis and colitis due to radiation	0.454	0.546	0.000
C43 Malignant melanoma of skin	0.451	0.549	0.000
C74 Malignant neoplasm of adrenal gland	0.450	0.550	0.000
C95.7 Other leukaemia of unspecified cell type	0.450	0.550	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.450	0.550	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.450	0.550	0.000
C95.0 Acute leukaemia of unspecified cell type	0.450	0.550	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.442	0.557	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.442	0.557	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.442	0.557	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.442	0.557	0.000
C84.3 Lymphoepithelioid lymphoma	0.442	0.557	0.000
C84.2 T-zone lymphoma	0.442	0.557	0.000
C84.1 Sezary's diease	0.442	0.557	0.000
E40-E46 Malnutrition	0.000	0.559	0.441
C84.0 Mycosis fungoides	0.440	0.560	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.000	0.560	0.440
E32 Diseases of thymus	0.000	0.560	0.440
E31 Polyglandular dysfunction	0.000	0.560	0.440
E30 Disorders of puberty, not elsewhere classified	0.000	0.560	0.440
E25 Adrenogenital disorders	0.000	0.560	0.440
D59.1 Other autoimmune haemolytic anaemias	0.000	0.563	0.437
E20 Hypoparathyroidism	0.000	0.565	0.435
E22.0 Acromegaly and pituitary gigantism	0.000	0.565	0.435
C88.9 Malignant immunoproliferative disease, unspecified	0.432	0.568	0.000
C88.7 Other malignant immunoproliferative diseases	0.432	0.568	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.432	0.568	0.000
C88.3 Immunoproliferative small intestinal disease	0.432	0.568	0.000
C88.2 Gamma heavy chain disease	0.432	0.568	0.000
C88.1 Alpha heavy chain disease	0.432	0.568	0.000
D81.9 Combined immunodeficiency, unspecified	0.000	0.569	0.431
D81.8 Other combined immunodeficiencies	0.000	0.569	0.431
D81.7 Major histocompatibility complex class II deficiency	0.000	0.569	0.431
D81.6 Major histocompatibility complex class I deficiency	0.000	0.569	0.431
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.000	0.569	0.431
D81.4 Nezelof's syndrome	0.000	0.569	0.431
D81.3 Adenosine deaminase [ADA] deficiency	0.000	0.569	0.431
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.000	0.569	0.431
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.000	0.569	0.431
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.000	0.569	0.431
D82.9 Immunodeficiency associated with major defect, unspecified	0.000	0.569	0.431
D82.8 Immunodeficiency associated with other specified major defects	0.000	0.569	0.431
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.000	0.569	0.431
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.000	0.569	0.431
D82.2 Immunodeficiency with short-limbed stature	0.000	0.569	0.431
D82.1 Di George's syndrome	0.000	0.569	0.431
D82.0 Wiskott-Aldrich syndrome	0.000	0.569	0.431
E27.5 Adrenomedullary hyperfunction	0.000	0.569	0.431
E27.0 Other adrenocortical overactivity	0.000	0.569	0.431
E27.3 Drug-induced adrenocortical insufficiency	0.000	0.571	0.429
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.000	0.572	0.428
E34 Other endocrine disorders	0.000	0.574	0.425
E13.8 With unspecified complications	0.000	0.576	0.424
E13.7 With multiple complications	0.000	0.576	0.424
E13.6 With other specified complications	0.000	0.576	0.424
E13.5 With peripheral circulatory complications	0.000	0.576	0.424
E13.4 With neurological complications	0.000	0.576	0.424
E13.3 With ophthalmic complications	0.000	0.576	0.424
E13.2 With renal complications	0.000	0.576	0.424
E13.1 With ketoacidosis	0.000	0.576	0.424
E13.0 With coma	0.000	0.576	0.424
D53.8 Other specified nutritional anaemias	0.000	0.577	0.423
D53.2 Scorbutic anaemia	0.000	0.577	0.423
D53.1 Other megaloblastic anaemias, not elsewhere classified	0.000	0.577	0.423
D53.0 Protein deficiency anaemia	0.000	0.577	0.423
C02 Malignant neoplasm of other and unspecified parts of tongue	0.422	0.578	0.000
E65-E68 Obesity and other hyperalimentation	0.000	0.582	0.418
D57 Sickle-cell disorders	0.000	0.582	0.417
D55 Anaemia due to enzyme disorders	0.000	0.582	0.417
C84.4 Peripheral T-cell lymphoma	0.416	0.584	0.000
C84.5 Other and unspecified T-cell lymphomas	0.412	0.587	0.000
C91.5 Adult T-cell leukaemia	0.410	0.589	0.000
E21.0 Primary hyperparathyroidism	0.000	0.594	0.406
C43.6 Malignant melanoma of upper limb, including shoulder	0.403	0.597	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.000	0.600	0.400
E22.8 Other hyperfunction of pituitary gland	0.000	0.600	0.400
E22.1 Hyperprolactinaemia	0.000	0.600	0.400
E14.3 With ophthalmic complications	0.000	0.601	0.399
D53.9 Nutritional anaemia, unspecified	0.000	0.602	0.397
C95.9 Leukaemia, unspecified	0.395	0.604	0.000
E14.8 With unspecified complications	0.000	0.606	0.394
E14.7 With multiple complications	0.000	0.606	0.394
E14.2 Withrenal complications	0.000	0.606	0.394
E14.1 With ketoacidosis	0.000	0.606	0.394
E14.0 With coma	0.000	0.606	0.394
C75 Malignant neoplasm of other endocrine glands and related structures	0.391	0.608	0.000
D50.0 Iron deficiency anaemia secondary to blood loss (chronic)	0.000	0.610	0.390
C91.9 Lymphoid leukaemia, unspecified	0.389	0.610	0.001
E27.8 Other specified disorders of adrenal gland	0.000	0.610	0.389
C40-C41 Malignant neoplasms of bone and articular cartilage	0.389	0.611	0.000
C43.4 Malignant melanoma of scalp and neck	0.389	0.611	0.000
E12.9 Without complications	0.000	0.612	0.388
E12.8 With unspecified complications	0.000	0.612	0.388
E12.7 With multiple complications	0.000	0.612	0.388
E12.6 With other specified complications	0.000	0.612	0.388
E12.5 With peripheral circulatory complications	0.000	0.612	0.388
E12.4 With neurological complications	0.000	0.612	0.388
E12.3 With ophthalmic complications	0.000	0.612	0.388
E12.2 With renal complications	0.000	0.612	0.388
E12.1 With ketoacidosis	0.000	0.612	0.388
E12.0 With coma	0.000	0.612	0.388
C02.1 Border of tongue	0.383	0.617	0.000
C83.0 Small cell (diffuse)	0.380	0.619	0.001
E14.6 With other specified complications	0.000	0.621	0.379
C90.3 Solitary plasmacytoma	0.377	0.623	0.000
C90.1 Plasma cell leukaemia	0.377	0.623	0.000
D83.8 Other common variable immunodeficiencies	0.000	0.624	0.376
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.000	0.624	0.376
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.000	0.624	0.376
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.000	0.624	0.376
E29 Testicular dysfunction	0.000	0.624	0.376
E14.5 With peripheral circulatory complications	0.000	0.625	0.375
C06 Malignant neoplasm of other and unspecified parts of mouth	0.372	0.628	0.000
C05 Malignant neoplasm of palate	0.369	0.631	0.000
E24.9 Cushing's syndrome, unspecified	0.000	0.631	0.369
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.368	0.632	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.000	0.632	0.368
D59.9 Acquired haemolytic anaemia, unspecified	0.000	0.633	0.367
J45 Asthma	0.000	0.637	0.363
C74.0 Cortex of adrenal gland	0.358	0.641	0.000
D59.8 Other acquired haemolytic anaemias	0.000	0.641	0.358
D59.6 Haemoglobinuria due to haemolysis from other external causes	0.000	0.641	0.358
D59.5 Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]	0.000	0.641	0.358
D59.4 Other nonautoimmune haemolytic anaemias	0.000	0.641	0.358
D59.3 Haemolytic-uraemic syndrome	0.000	0.641	0.358
D59.2 Drug-induced nonautoimmune haemolytic anaemia	0.000	0.641	0.358
D59.0 Drug-induced autoimmune haemolytic anaemia	0.000	0.641	0.358
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.000	0.642	0.357
D80.8 Other immunodeficiencies with predominantly antibody defects	0.000	0.642	0.357
D80.7 Transient hypogammaglobulinaemia of infancy	0.000	0.642	0.357
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.000	0.642	0.357
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.000	0.642	0.357
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.000	0.642	0.357
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.000	0.642	0.357
D80.0 Hereditary hypogammaglobulinaemia	0.000	0.642	0.357
C74.9 Adrenal gland, unspecified	0.354	0.646	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.353	0.646	0.000
D56 Thalassaemia	0.000	0.646	0.353
E00-E07 Disorders of thyroid gland	0.000	0.647	0.353
M06.9 Rheumatoid arthritis, unspecified	0.352	0.648	0.000
M06.0 Seronegative rheumatoid arthritis	0.350	0.650	0.000
E34.0 Carcinoid syndrome	0.000	0.650	0.349
M06 Other rheumatoid arthritis	0.349	0.651	0.000
C03 Malignant neoplasm of gum	0.349	0.651	0.000
E14.4 With neurological complications	0.000	0.652	0.348
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.347	0.653	0.000
D84.8 Other specified immunodeficiencies	0.001	0.653	0.346
D84.1 Defects in the complement system	0.001	0.653	0.346
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.001	0.653	0.346
E21.5 Disorder of parathyroid gland, unspecified	0.000	0.653	0.347
E21.4 Other specified disorders of parathyroid gland	0.000	0.653	0.347
E21.2 Other hyperparathyroidism	0.000	0.653	0.347
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.346	0.654	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.343	0.657	0.001
C91.7 Other lymphoid leukaemia	0.343	0.657	0.001
C91.6 Prolymphocytic leukaemia of T-cell type	0.343	0.657	0.001
C91.3 Prolymphocytic leukaemia	0.343	0.657	0.001
C91.2 Subacute lymphocytic leukaemia	0.343	0.657	0.001
C92 Myeloid leukaemia	0.340	0.659	0.001
C10 Malignant neoplasm of oropharynx	0.340	0.660	0.000
E24.8 Other Cushing's syndrome	0.000	0.662	0.338
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.000	0.662	0.338
E24.3 Ectopic ACTH syndrome	0.000	0.662	0.338
E24.2 Drug-induced Cushing's syndrome	0.000	0.662	0.338
E24.1 Nelson's syndrome	0.000	0.662	0.338
E24.0 Pituitary-dependent Cushing's disease	0.000	0.662	0.338
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.338	0.662	0.000
D58 Other hereditary haemolytic anaemias	0.000	0.666	0.334
C00 Malignant neoplasm of lip	0.330	0.670	0.000
C02.2 Ventral surface of tongue	0.330	0.670	0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.330	0.670	0.000
C02.9 Tongue, unspecified	0.329	0.671	0.000
C13 Malignant neoplasm of hypopharynx	0.326	0.674	0.000
C08 Malignant neoplasm of other and unspecified major salivary glands	0.326	0.674	0.000
C90.0 Multiple myeloma	0.324	0.676	0.000
C43.8 Overlapping malignant melanoma of skin	0.323	0.676	0.000
C43.1 Malignant melanoma of eyelid, including canthus	0.323	0.676	0.000
C43.0 Malignant melanoma of lip	0.323	0.676	0.000
C74.1 Medulla of adrenal gland	0.323	0.677	0.000
D80.1 Nonfamilial hypogammaglobulinaemia	0.000	0.680	0.320
C12 Malignant neoplasm of pyriform sinus	0.319	0.681	0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.318	0.682	0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.317	0.682	0.000
E44 Protein-energy malnutrition of moderate and mild degree	0.000	0.684	0.316
E45 Retarded development following protein-energy malnutrition	0.000	0.684	0.316
E43 Unspecified severe protein-energy malnutrition	0.000	0.684	0.316
E42 Marasmic kwashiorkor	0.000	0.684	0.316
E41 Nutritional marasmus	0.000	0.684	0.316
E40 Kwashiorkor	0.000	0.684	0.316
C43.2 Malignant melanoma of ear and external auricular canal	0.316	0.684	0.000
E25.9 Adrenogenital disorder, unspecified	0.000	0.684	0.315
E25.8 Other adrenogenital disorders	0.000	0.684	0.315
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.000	0.684	0.315
E30.9 Disorder of puberty, unspecified	0.000	0.684	0.315
E30.8 Other disorders of puberty	0.000	0.684	0.315
E30.1 Precocious puberty	0.000	0.684	0.315
E30.0 Delayed puberty	0.000	0.684	0.315
E31.9 Polyglandular dysfunction, unspecified	0.000	0.684	0.315
E31.8 Other polyglandular dysfunction	0.000	0.684	0.315
E31.1 Polyglandular hyperfunction	0.000	0.684	0.315
E31.0 Autoimmune polyglandular failure	0.000	0.684	0.315
E32.9 Disease of thymus, unspecified	0.000	0.684	0.315
E32.8 Other diseases of thymus	0.000	0.684	0.315
E32.1 Abscess of thymus	0.000	0.684	0.315
E32.0 Persistent hyperplasia of thymus	0.000	0.684	0.315
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.000	0.684	0.315
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.000	0.684	0.315
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.000	0.684	0.315
C11 Malignant neoplasm of nasopharynx	0.313	0.687	0.000
E20.8 Other hypoparathyroidism	0.000	0.688	0.312
E20.1 Pseudohypoparathyroidism	0.000	0.688	0.312
E20.0 Idiopathic hypoparathyroidism	0.000	0.688	0.312
E66 Obesity	0.000	0.688	0.312
E03 Other hypothyroidism	0.000	0.689	0.311
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.000	0.691	0.309
E20.9 Hypoparathyroidism, unspecified	0.000	0.692	0.308
D89.9 Disorder involving the immune mechanism, unspecified	0.000	0.693	0.307
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.000	0.693	0.307
D89.3 Immune reconstitution syndrome	0.000	0.693	0.307
D89.0 Polyclonal hypergammaglobulinaemia	0.000	0.693	0.307
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.000	0.693	0.306
E34.5 Androgen resistance syndrome	0.000	0.695	0.305
E34.4 Constitutional tall stature	0.000	0.695	0.305
E34.3 Short stature, not elsewhere classified	0.000	0.695	0.305
E34.2 Ectopic hormone secretion, not elsewhere classified	0.000	0.695	0.305
E34.1 Other hypersecretion of intestinal hormones	0.000	0.695	0.305
M06.09 Seronegative rheumatoid arthritis (Site unspecified)	0.304	0.696	0.000
C02.8 Overlapping lesion of tongue	0.303	0.697	0.000
C02.4 Lingual tonsil	0.303	0.697	0.000
C02.3 Anterior two-thirds of tongue, part unspecified	0.303	0.697	0.000
C02.0 Dorsal surface of tongue	0.303	0.697	0.000
E05 Thyrotoxicosis [hyperthyroidism]	0.000	0.698	0.302
C90.2 Plasmacytoma, extramedullary	0.301	0.698	0.000
C81.9 Hodgkin's disease, unspecified	0.301	0.699	0.000
C06.0 Cheek mucosa	0.301	0.699	0.000
E67 Other hyperalimentation	0.000	0.700	0.300
E68 Sequelae of hyperalimentation	0.000	0.700	0.300
D55.9 Anaemia due to enzyme disorder, unspecified	0.000	0.700	0.299
D55.8 Other anaemias due to enzyme disorders	0.000	0.700	0.299
D55.3 Anaemia due to disorders of nucleotide metabolism	0.000	0.700	0.299
D55.2 Anaemia due to disorders of glycolytic enzymes	0.000	0.700	0.299
D55.1 Anaemia due to other disorders of glutathione metabolism	0.000	0.700	0.299
D55.0 Anaemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency	0.000	0.700	0.299
D57.8 Other sickle-cell disorders	0.000	0.700	0.299
D57.3 Sickle-cell trait	0.000	0.700	0.299
D57.2 Double heterozygous sickling disorders	0.000	0.700	0.299
D57.1 Sickle-cell anaemia without crisis	0.000	0.700	0.299
D57.0 Sickle-cell anaemia with crisis	0.000	0.700	0.299
D83.9 Common variable immunodeficiency, unspecified	0.001	0.701	0.298
C43.3 Malignant melanoma of other and unspecified parts of face	0.296	0.704	0.000
M06.98 Rheumatoid arthritis, unspecified (Other)	0.295	0.705	0.000
C05.1 Soft palate	0.293	0.707	0.000
E21.3 Hyperparathyroidism, unspecified	0.000	0.709	0.291
E05.0 Thyrotoxicosis with diffuse goitre	0.000	0.713	0.287
E03.9 Hypothyroidism, unspecified	0.000	0.714	0.286
C05.0 Hard palate	0.285	0.715	0.000
E28 Ovarian dysfunction	0.000	0.715	0.284
K52.9 Non-infective gastro-enteritis and colitis, unspecified	0.283	0.717	0.000
E46 Unspecified protein-energy malnutrition	0.000	0.718	0.282
C91.0 Acute lymphoblastic leukaemia	0.281	0.718	0.001
E34.8 Other specified endocrine disorders	0.000	0.719	0.281
C75.9 Endocrine gland, unspecified	0.281	0.719	0.000
C75.8 Pluriglandular involvement, unspecified	0.281	0.719	0.000
C75.5 Aortic body and other paraganglia	0.281	0.719	0.000
C75.4 Carotid body	0.281	0.719	0.000
C75.3 Pineal gland	0.281	0.719	0.000
C75.2 Craniopharyngeal duct	0.281	0.719	0.000
C75.1 Pituitary gland	0.281	0.719	0.000
C75.0 Parathyroid gland	0.281	0.719	0.000
C04 Malignant neoplasm of floor of mouth	0.279	0.721	0.000
C06.2 Retromolar area	0.279	0.721	0.000
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)	0.279	0.721	0.000
C40 Malignant neoplasm of bone and articular cartilage of limbs	0.279	0.721	0.000
E50-E64 Other nutritional deficiencies	0.000	0.721	0.279
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.276	0.724	0.000
C01 Malignant neoplasm of base of tongue	0.273	0.727	0.000
C03.1 Lower gum	0.273	0.727	0.000
D70-D77 Other diseases of blood and blood-forming organs	0.000	0.728	0.272
C06.9 Mouth, unspecified	0.271	0.729	0.000
E29.9 Testicular dysfunction, unspecified	0.000	0.730	0.269
E29.8 Other testicular dysfunction	0.000	0.730	0.269
E29.0 Testicular hyperfunction	0.000	0.730	0.269
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.269	0.731	0.000
C06.8 Overlapping lesion of other and unspecified parts of mouth	0.267	0.733	0.000
C06.1 Vestibule of mouth	0.267	0.733	0.000
D89.1 Cryoglobulinaemia	0.000	0.734	0.266
M06.06 Seronegative rheumatoid arthritis (Lower leg)	0.265	0.735	0.000
C05.9 Palate, unspecified	0.265	0.735	0.000
C05.8 Overlapping lesion of palate	0.265	0.735	0.000
C05.2 Uvula	0.265	0.735	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.264	0.736	0.000
E27.9 Disorder of adrenal gland, unspecified	0.001	0.736	0.263
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.263	0.736	0.000
C69 Malignant neoplasm of eye and adnexa	0.263	0.737	0.000
J45.8 Mixed asthma	0.000	0.740	0.260
J45.1 Nonallergic asthma	0.000	0.740	0.260
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.259	0.741	0.000
C43.7 Malignant melanoma of lower limb, including hip	0.258	0.742	0.000
C10.9 Oropharynx, unspecified	0.258	0.742	0.000
E26 Hyperaldosteronism	0.002	0.743	0.256
D56.9 Thalassaemia, unspecified	0.000	0.746	0.253
D56.8 Other thalassaemias	0.000	0.746	0.253
D56.4 Hereditary persistence of foetal haemoglobin [HPFH]	0.000	0.746	0.253
D56.2 Delta-beta thalassaemia	0.000	0.746	0.253
D56.0 Alpha thalassaemia	0.000	0.746	0.253
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.746	0.253
E00 Congenital iodine-deficiency syndrome	0.000	0.746	0.253
C43.9 Malignant melanoma of skin, unspecified	0.252	0.748	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.251	0.749	0.000
M06.08 Seronegative rheumatoid arthritis (Other)	0.251	0.749	0.000
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)	0.251	0.749	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations